MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2023

Sep 27, 2023

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

28 September 2023

MACH7 SIGNS CONTRACT EXTENSION WITH TOTAL VALUE OF $15.26M

• Hospital Authority of Hong Kong renews five-year Service and Support agreement

• Continuation of Support and Maintenance for 5 years

• Professional Services value of $2.9m

Mach7 Technologies Limited (“ M7T” or “the Company” ) (ASX:M7T) is pleased to announce that it has received a signed extension agreement from the Hospital Authority of Hong Kong (“HAHK”). HAHK is an anchor site for the Mach7 expansion throughout the APAC region.

The agreement is for a five-year extension of HAHK VNA and eUnity Support and Maintenance along with professional services that will be delivered and recognized on an as needed basis through the contract extension. The total value of the extension is $15.26m, with a recurring revenue value of $12.36 ($2.47m annually) that will be recognized over the course of the extension. The professional services component is $2.9m which will be delivered and recognized over the course of the extension on an as needed basis.

CEO of Mach7 Mike Lampron said: “We are pleased to see continued support from this very important and long-standing client. This long-term commitment shows the value that Mach7 brings to our clients and the deep-rooted partnerships that develop over time.

The inclusion of professional services in this extension further illustrates how our product can continue to add value through increased use cases beyond what was imaginable at contract inception.”

Released on authority of the Board by:

Mike Lampron Managing Director and Chief Executive Officer

For more information, contact: Investor Relations

Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com

==> picture [104 x 26] intentionally omitted <==

ASX Announcement

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T), founded in 2007, is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organizations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Departmental Workflow applications. eUnity is a zerofootprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. With more than 165 customers across 15 different countries, Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com